Wenjun Cheng

10PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
FRα expression in borderline ovarian tumors and low-grade serous ovarian carcinoma: prognostic and immune microenvironmental associations.

|Apr 15, 2026
Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity.

|Dec 08, 2025
IL7R remodels immunosuppression tumor microenvironment and promotes macrophage polarization by regulating NF-κB/CXCL1 axis in ovarian cancer.

Yeqing Zheng, Cheng Qian, Shuyi Zhang

|Sep 11, 2024
Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database.

Xianglin Nie, Ting Xu, Wenjun Cheng

|Jun 21, 2024
The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer.

Yi Liu, Lin Yuan, Zhang Lin

|Feb 19, 2024
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism.

Huixian Miao, Huangyang Meng, Yashuang Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Lin Zhang

2 joint publications

Huixian Miao

1 joint publications

Aining Zhang

1 joint publications

Ting Chen